“Nibima” - a herbal product, prepared by a team of Ghanaian scientists, is showing encouraging signs – positive signs of efficacy, in the treatment of the flu-like virus – COVID-19 that has brought so much pain, devasted global economies and changed the way of life of people across the world.
This could be a major contribution of Ghana to global science.
Professor Christian Agyare, Provost of the College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), told journalists that the product was undergoing testing and approval by the Food and Drugs Authority (FDA).
It was developed by the University’s Department of Clinical Microbiology.
Globally, there are 241,170,384 cases of the virus infection and the total number of people, who have recovered from the disease stands at 218,749,711. Worldwide, 4,910,066 people have been killed by the virus, which was first detected in China’s Wuhan Province, in December 2019.
Pro Agyare said results from laboratory tests conducted by the University’s research scientists pointed to the efficacy of the product.
They were working closely with the FDA and he said they were confident that approval would be given by the Authority for its use in the treatment of the virus.
The scientists, he added, were anticipating positive results from the FDA.
Prof Agyare said, they were resolute in their determination to put the material resources, their expertise and knowledge at the serve of humanity, to make the society a better place to live.
This was why the Kumasi Centre for Collaborative Research (KCCR) had been at the forefront of the country’s COVID-19 response – efforts at helping to stop the spread of the infection.
The KCCR since Ghana’s first reported case of the virus on March 12, 2020, has conducted more than 165,455 tests.
These were from the Ashanti, Bono, Bono East, Ahafo, Northern, Savannah, North East, Upper West, Upper East, Central, Western and Western North Regions.
Prof Agyare said the KCCR was also one of the main centres coordinating the administration of the COVID-19 vaccines – AstraZeneca and the Johnson and Johnson vaccines.
Content created and supplied by: KyeretwienanaOseiBonsu (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More